Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.82
$0.00 (0.00%)
Nov 2, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 7.19B | 15.55B | 7.88B | 8.06B | 5.88B | 8.78B | 8.69B | 8.14B | 10.63B | 30M | 7.33B | 8.87B | 10.41B | 1.12B | 5.97B | -28.7B | 6.66B | 7.88B | 5.04B | 6.97B | 7.38B |
Depreciation & Amortization | 4.72B | 4.55B | 4.62B | 4.69B | 4.5B | 4.4B | 4.51B | 4.34B | 4.71B | 4.56B | 4.69B | 4.9B | 4.03B | 4.1B | 4.13B | 4.55B | 4.47B | 4.51B | 4.24B | 4.49B | 3.81B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -4.81B | 5.38B | -803M | -2.01B | -3.55B | 4.12B | 1.09B | -462M | -4.67B | 2.57B | 8.8B | -2.27B | -8.04B | 2.48B | 2.52B | 560M | -8.12B | 72M | 2.16B | -563M | -5.72B |
Other Non-Cash Items | -2.43B | 846M | -912M | 1.38B | -745M | 3.67B | -1.57B | 861M | -2.03B | 8.15B | 2.7B | 4.3B | -3.01B | 11.87B | -1.33B | 31.07B | -288M | 2.28B | -2.12B | 1.36B | -1.65B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.22B | 34M | -2.63B | -8.28B | -1.91B | 2.04B | 2.1B | 2.83B | -1.17B | 468M | 16.99B | 7.13B | -8.89B | -8.42B | 1.38B | 9B | -8.42B | 187M | -3.07B | 11.74B | -7.01B |
Operating Cash Flow | 5.26B | 20.98B | 8.95B | 5.85B | 7.72B | 18.89B | 13.73B | 16.17B | 12.14B | 13.21B | 31.71B | 25.19B | 2.54B | 8.67B | 10.15B | 15.91B | 2.42B | 14.86B | 4.09B | 24.56B | 2.54B |
Capital Expenditures | -952M | -1.89B | -1.57B | -1.53B | -1.86B | -927M | -3.06B | -2.1B | -575M | -3.31B | -1.36B | -2.16B | -2.48B | -2.83B | -3.21B | -8.04B | -3.2B | -2.42B | -5.13B | -7.67B | -2.13B |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -107M | -2M | -103M | n/a | -1.57B | n/a | -2M | n/a | -8M | -359M | -6M | -135M | -3M | -273M | -3.43B | -351M | -244M | -497M | -2.77B | -523M |
Sales Maturities Of Investments | 115M | 328M | 244M | n/a | n/a | 3.43B | 1.29B | n/a | n/a | 3.36B | n/a | 380M | 388M | 660M | 498M | 524M | 467M | 2.77B | 352M | 363M | 383M |
Other Investing Acitivies | 56M | 970M | -6M | 13M | -45M | -72M | -248M | -7M | -29M | 101M | 38M | 800M | -16M | 94M | -278M | -2M | -93M | 868M | -25M | -3M | -2M |
Investing Cash Flow | -900M | -1.36B | -2.05B | -7.38B | -2.19B | -976M | -2.77B | -3.46B | -1.02B | -416M | -1.95B | -1.08B | -2.7B | -3.18B | -4.79B | -12.59B | -6.23B | -11.93B | -6.18B | -12.18B | -4.88B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 1M | n/a | -159M | n/a | -1.79B | -102M | -216M | n/a | -22M | -72M | 4.46B | n/a | 10.46B | n/a | 10B | n/a |
Common Stock Repurchased | -955M | -2M | -5B | -19.74B | -8.05B | n/a | -13.51B | -12.29B | -12.08B | n/a | -5.18B | -4.74B | -7.04B | -8.1B | -4.9B | -5.81B | -7.2B | n/a | n/a | n/a | n/a |
Dividend Paid | -6.05B | -68M | -6.1B | -71M | -6.41B | -67M | -5.88B | -71M | -6.1B | -89M | -5.78B | -88M | -5.92B | -101M | -6.1B | -82M | -6.32B | -83M | -6.32B | -84M | -5.51B |
Other Financial Acitivies | -884M | -1.44B | -773M | -808M | -884M | -795M | -828M | -769M | -763M | -828M | -590M | -854M | -804M | -1B | -795M | -914M | -255M | -672M | -805M | -771M | -661M |
Financial Cash Flow | -7.89B | -1.51B | -11.87B | -20.62B | -15.34B | -861M | -20.22B | -13.29B | -18.94B | -2.71B | -11.66B | -5.9B | -13.76B | -9.23B | -11.87B | -2.35B | -13.77B | 9.71B | -7.12B | 9.15B | -6.17B |
Net Cash Flow | -2.62B | 19.33B | -2.02B | -21.02B | -8.42B | 15.15B | -6.59B | -5.3B | -4.84B | 12.55B | 17.3B | 19.22B | -12.39B | -3.32B | -7.92B | 565M | -14.44B | 15.18B | -8.2B | 21.34B | -8.19B |
Free Cash Flow | 4.31B | 19.09B | 7.38B | 4.32B | 5.86B | 17.96B | 10.67B | 14.07B | 11.56B | 9.9B | 30.34B | 23.03B | 63M | 5.84B | 6.94B | 7.87B | -783M | 12.43B | -1.04B | 16.89B | 414M |
Adj. Free Cash Flow | 4.31B | 19.09B | 7.38B | 4.32B | 5.86B | 17.96B | 10.67B | 14.07B | 11.56B | 9.9B | 30.34B | 23.03B | 63M | 5.84B | 6.94B | 7.87B | -783M | 12.43B | -1.04B | 16.89B | 414M |
Maintenance CapEx | -952M | -1.1B | -1.57B | -1.53B | -1.86B | -927M | -3.06B | -2.1B | -99.51M | -3.31B | -231.91M | -317.56M | -1.22B | -1.33B | -2.56B | -8.04B | -3.11B | -2.01B | -4.48B | -7.29B | -977.07M |
Growth CapEx | n/a | -790.29M | n/a | n/a | n/a | n/a | n/a | n/a | -475.49M | n/a | -1.13B | -1.85B | -1.26B | -1.49B | -649.67M | n/a | -92.81M | -408.15M | -644.04M | -376.27M | -1.15B |
Owner Earnings | 4.31B | 19.88B | 7.38B | 4.32B | 5.86B | 17.96B | 10.67B | 14.07B | 12.04B | 9.9B | 31.48B | 24.87B | 1.32B | 7.33B | 7.59B | 7.87B | -690.19M | 12.84B | -392.96M | 17.27B | 1.56B |
Add to Watchlist
Select watchlists to add or remove SNPHY